Rufinamide 40 mg/mL

Rufinamide 40 mg/mL oral suspension is a medication used to manage certain types of seizures. This liquid form is designed for easy administration, particularly for those who have difficulty swallowing pills.

Rufinamide is primarily used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy. It works by affecting the electrical activity in the brain, helping to reduce the frequency and severity of seizures. Rufinamide 40 mg/mL suspension is formulated for oral use, making it a convenient option for patients who require liquid medication.

Common effects of Rufinamide may include dizziness, headache, and fatigue. Some users might experience nausea or vomiting. These effects can vary from person to person, and it's important to monitor how the body responds to the medication.

Rufinamide should be used under medical supervision. It is important to follow the prescribed dosage and administration instructions. Patients with a history of heart problems or liver issues should discuss these conditions with their healthcare provider before starting Rufinamide.

Rufinamide may interact with other medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain over-the-counter drugs may also interact with Rufinamide, so caution is recommended.